← Open Payments lookup

DENNIS DOBARD: Open Payments

NPI 1063554038 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,812 in 154 payments from 16 companies in 2025. Trend: 2023 $2,279 · 2024 $2,438 · 2025 $2,812

Food & beverage: $2,742Education: $70
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.24$351
Teva Pharmaceuticals USA, Inc.13$338
Supernus Pharmaceuticals, Inc.18$320
E.R. Squibb & Sons, L.L.C.18$311
Neurocrine BioSciences, Inc.14$268
Alkermes, Inc.14$253
Axsome Therapeutics, Inc.5$214
Vanda Pharmaceuticals Inc.16$194
Janssen Pharmaceuticals, Inc10$157
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$141

Products named: Qelbree, COBENFY, INGREZZA, ARISTADA, REXULTI, Auvelity, AUSTEDO XR, ABILIFY ASIMTUFII.

Industry payments across MO — which companies pay providers there.